Mohammad Dara K, Nore Beston F, Gustafsson Manuela O, Mohamed Abdalla J, Smith C I Edvard
Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Karolinska Hospital Huddinge, SE-141 86 Huddinge, Stockholm, Sweden; Department of Biology, College of Science, University of Salahaddin, Erbil, Kurdistan Region, Iraq.
Department of Laboratory Medicine, Clinical Research Center, Karolinska Institutet, Karolinska Hospital Huddinge, SE-141 86 Huddinge, Stockholm, Sweden; Department of Biochemistry, School of Medicine, University of Sulaimani, Sulaimaniyah, Kurdistan Region, Iraq.
Int J Biochem Cell Biol. 2016 Sep;78:63-74. doi: 10.1016/j.biocel.2016.06.024. Epub 2016 Jul 2.
The Protein kinase B (AKT) regulates a plethora of intracellular signaling proteins to fine-tune signaling of multiple pathways. Here, we found that following B-cell receptor (BCR)-induced tyrosine phosphorylation of the cytoplasmic tyrosine kinase SYK and the adaptor BLNK, the AKT/PKB enzyme strongly induced BLNK (>100-fold) and SYK (>100-fold) serine/threonine phosphorylation (pS/pT). Increased phosphorylation promoted 14-3-3 binding to BLNK (37-fold) and SYK (2.5-fold) in a pS/pT-concentration dependent manner. We also demonstrated that the AKT inhibitor MK2206 reduced pS/pT of both BLNK (3-fold) and SYK (2.5-fold). Notably, the AKT phosphatase, PHLPP2 maintained the activating phosphorylation of BLNK at Y84 and increased protein stability (8.5-fold). In addition, 14-3-3 was required for the regulation SYK's interaction with BLNK and attenuated SYK binding to Importin 7 (5-fold), thereby perturbing shuttling to the nucleus. Moreover, 14-3-3 proteins also sustained tyrosine phosphorylation of SYK and BLNK. Furthermore, substitution of S295 or S297 for alanine abrogated SYK's binding to Importin 7. SYK with S295A or S297A replacements showed intense pY525/526 phosphorylation, and BLNK pY84 phosphorylation correlated with the SYK pY525/526 phosphorylation level. Conversely, the corresponding mutations to aspartic acid in SYK reduced pY525/526 phosphorylation. Collectively, these and previous results suggest that AKT and 14-3-3 proteins down-regulate the activity of several BCR-associated components, including BTK, BLNK and SYK and also inhibit SYK's interaction with Importin 7.
蛋白激酶B(AKT)调节众多细胞内信号蛋白,以微调多条信号通路。在此,我们发现,在B细胞受体(BCR)诱导细胞质酪氨酸激酶SYK和衔接蛋白BLNK发生酪氨酸磷酸化后,AKT/PKB酶强烈诱导BLNK(>100倍)和SYK(>100倍)的丝氨酸/苏氨酸磷酸化(pS/pT)。磷酸化增加以pS/pT浓度依赖的方式促进14-3-3与BLNK(37倍)和SYK(2.5倍)结合。我们还证明,AKT抑制剂MK2206降低了BLNK(3倍)和SYK(2.5倍)的pS/pT。值得注意的是,AKT磷酸酶PHLPP2维持BLNK在Y84位点的激活磷酸化,并增加蛋白质稳定性(8.5倍)。此外,14-3-3是调节SYK与BLNK相互作用所必需的,并减弱SYK与输入蛋白7的结合(5倍),从而干扰其向细胞核的穿梭。此外,14-3-3蛋白还维持SYK和BLNK的酪氨酸磷酸化。此外,将S295或S297替换为丙氨酸可消除SYK与输入蛋白7的结合。替换为S295A或S297A的SYK显示出强烈的pY525/526磷酸化,并且BLNK的pY84磷酸化与SYK的pY525/526磷酸化水平相关。相反,SYK中相应的天冬氨酸突变降低了pY525/526磷酸化。总体而言,这些以及之前的结果表明,AKT和14-3-3蛋白下调几种BCR相关成分的活性,包括BTK、BLNK和SYK,并且还抑制SYK与输入蛋白7的相互作用。